The Vascular Biology of Atherosclerosis

[1]  P. Libby,et al.  Diversity of denizens of the atherosclerotic plaque: not all monocytes are created equal. , 2008, Circulation.

[2]  P. Libby.  The molecular mechanisms of the thrombotic complications of atherosclerosis , 2008, Journal of internal medicine.

[3]  M. Majesky.  Developmental basis of vascular smooth muscle diversity. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[4]  P. Kostenuik,et al.  Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr(−/−) Mice , 2008, Circulation.

[5]  T. V. van Berkel,et al.  Scavenger receptors: friend or foe in atherosclerosis? , 2005, Current opinion in lipidology.

[6]  P. Shaw,et al.  Emerging approaches for imaging vulnerable plaques in patients. , 2007, Current opinion in biotechnology.

[7]  J. Berger,et al.  Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. , 2005, JAMA.

[8]  G. Biondi-Zoccai,et al.  Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation , 2007, Heart.

[9]  E. Brilakis,et al.  Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. , 2005, The New England journal of medicine.

[10]  D. Simon,et al.  Hemizygous Deficiency of Krüppel-Like Factor 2 Augments Experimental Atherosclerosis , 2008, Circulation research.

[11]  A. Tedgui,et al.  Regulatory T‐cell immunity and its relevance to atherosclerosis , 2008, Journal of internal medicine.

[12]  T. Littlewood,et al.  Chronic Apoptosis of Vascular Smooth Muscle Cells Accelerates Atherosclerosis and Promotes Calcification and Medial Degeneration , 2008, Circulation research.

[13]  T. Littlewood,et al.  Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis , 2006, Nature Medicine.

[14]  M. Reed,et al.  Endothelial Precursor Cells , 2007, Stem Cell Reviews.

[15]  C. Gleissner,et al.  Platelet Chemokines in Vascular Disease , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[16]  Brian J. Bennett,et al.  Osteoprotegerin Inactivation Accelerates Advanced Atherosclerotic Lesion Progression and Calcification in Older ApoE−/− Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[17]  E. Falk,et al.  Smooth Muscle Cells in Atherosclerosis Originate From the Local Vessel Wall and Not Circulating Progenitor Cells in ApoE Knockout Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[18]  P. Libby,et al.  Pathophysiology of Coronary Artery Disease , 2005, Circulation.

[19]  Elena Galkina,et al.  Vascular adhesion molecules in atherosclerosis. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[20]  W. L. Ruzzo,et al.  Atherosclerotic Plaque Smooth Muscle Cells Have a Distinct Phenotype , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[21]  P. Libby.  Act local, act global: inflammation and the multiplicity of "vulnerable" coronary plaques. , 2005, Journal of the American College of Cardiology.

[22]  Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events , 2006 .

[23]  P. Libby,et al.  Progression of Atheroma: A Struggle Between Death and Procreation , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[24]  P. Libby,et al.  Mast cells as mediators and modulators of atherogenesis. , 2007, Circulation.

[25]  P. Goldschmidt-Clermont,et al.  Endothelial progenitor obsolescence and atherosclerotic inflammation. , 2005, Journal of the American College of Cardiology.

[26]  K. Moulton.  Angiogenesis in atherosclerosis: gathering evidence beyond speculation , 2006, Current opinion in lipidology.

[27]  Peter Libby,et al.  Atherosclerosis and proteinase activation. , 2006, Cardiovascular research.

[28]  R. Virmani,et al.  Pathology of the Vulnerable Plaque , 2006 .

[29]  Peter Libby,et al.  Inflammation and cellular immune responses in abdominal aortic aneurysms. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[30]  P. Libby,et al.  Vascular remodeling in transplant vasculopathy. , 2007, Circulation research.

[31]  Yuzhi Zhang,et al.  Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. , 2005, The Journal of clinical investigation.

[32]  Timur Shtatland,et al.  Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo , 2007, Circulation.

[33]  R. Nagai,et al.  Regulation of smooth muscle phenotype , 2003, Current atherosclerosis reports.

[34]  P. Libby,et al.  Local cytokine environments drive aneurysm formation in allografted aortas. , 2005, Trends in cardiovascular medicine.

[35]  W. Aird.  Mechanisms of endothelial cell heterogeneity in health and disease. , 2006, Circulation research.

[36]  Jeffrey L. Anderson.  Infection, antibiotics, and atherothrombosis--end of the road or new beginnings? , 2005, The New England journal of medicine.

[37]  J. Witztum,et al.  Oxidation‐specific epitopes are important targets of innate immunity , 2008, Journal of internal medicine.

[38]  J. Kappes,et al.  Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT Signaling* , 2008, Journal of Biological Chemistry.

[39]  H. Kruth.  Sequestration of aggregated low-density lipoproteins by macrophages , 2002, Current opinion in lipidology.

[40]  M. Bennett,et al.  Death Receptors and Their Ligands in Atherosclerosis , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[41]  George H. Thomas,et al.  Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .

[42]  J. Elefteriades,et al.  Transmural inflammation by interferon‐γ‐producing T cells correlates with outward vascular remodeling and intimal expansion of ascending thoracic aortic aneurysms , 2005 .

[43]  E. Falk,et al.  Smooth Muscle Cells Healing Atherosclerotic Plaque Disruptions Are of Local, Not Blood, Origin in Apolipoprotein E Knockout Mice , 2007, Circulation.

[44]  Mason W Freeman,et al.  Scavenger receptors in atherosclerosis: beyond lipid uptake. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[45]  J. Witztum,et al.  Natural antibodies in murine atherosclerosis. , 2008, Current drug targets.

[46]  Richard T. Lee,et al.  Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells , 2005 .

[47]  G. Lip,et al.  Endothelial progenitor cells in cardiovascular disorders. , 2007, Journal of the American College of Cardiology.

[48]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[49]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.